Healthcare Sep 09, 2022 04:12 PM (GMT+8) · EqualOcean
Trulive (Chinese: 臻亿医疗) recently completed a pre-Series B financing round worth hundreds of millions of CNY, which was led by Shanghai Daohe Long-term Investment (Chinese: 道禾长期投资) with participation from Ancheng Capital (Chinese: 安诚资本) and Jifeng Ventures (Chinese: 济峰资本). The funds will be used for the company's product development, clinical research and the promotion of product commercialization. Founded in 2019, Trulive is a high-end medical device company. The company's business covers heart valve, heart failure, peripheral and coronary artery diseases.